6 Results for "

S2 subsites

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "S2 subsites" in MCE Product Catalog:

Cat. No.: HY-125494
CAS No.: 155662-50-3
Synonyms: SC-55389A
Target:  

HIV HIV Protease

Research Areas:  

Infection

Droxinavir hydrochloride (SC-55389A) is an HIV-1 protease inhibitor. Droxinavir hydrochloride binds to the S2 and S2' subsites of HIV-1 protease, and this interaction is regulated by protease amino acid residue 88, where the N88S mutation confers viral resistance. Droxinavir hydrochloride can be used in studies related to human immunodeficiency virus type 1 infection .
loading...
    loading...
Cat. No.: HY-139866
CAS No.: 1453052-57-7
Target:  

SARS-CoV

Research Areas:  

Infection

SARS-CoV-2-IN-9 is an inhibitor binding to subsites S1 and S2 in SARS-CoV-2 main protease.
loading...
    loading...
Cat. No.: HY-125494A
CAS No.: 159910-86-8
Synonyms: SC-55389A free base
Target:  

HIV HIV Protease

Research Areas:  

Infection

Droxinavir (SC-55389A free base) is an HIV-1 protease inhibitor. Droxinavir binds to the S2 and S2' subsites of HIV-1 protease, and this interaction is regulated by protease amino acid residue 88, where the N88S mutation confers viral resistance. Droxinavir can be used in studies related to human immunodeficiency virus type 1 infection .
loading...
    loading...
Cat. No.: HY-184146
Target:  

SARS-CoV Virus Protease

Research Areas:  

Infection

AD05 is a SARS-CoV-2 main protease (M pro) inhibitor with an IC50 of 306.5 nM. AD05 exhibits antiviral activity against wild-type SARS-CoV-2 in host cells without inducing significant cytotoxicity. AD05 can be used in studies related to SARS-CoV-2 infection .
loading...
    loading...
Cat. No.: HY-184147
Target:  

SARS-CoV Virus Protease

Research Areas:  

Infection

AD06 is a SARS-CoV-2 main protease (M pro) inhibitor with an IC50 of 163.3 nM. AD06 undergoes nucleophilic attack by deprotonated Cys145, thereby blocking viral replication. AD06 inhibits the activity of wild-type SARS-CoV-2 and shows no significant cytotoxicity in mammalian cells. AD06 can be used in studies related to SARS-CoV-2 infection .
loading...
    loading...
Cat. No.: HY-183956
CAS No.: 2170616-59-6
Target:  

SARS-CoV

Research Areas:  

Infection

GC813 is a MERS-CoV 3CL protease (3CLpro) and MERS-CoV main protease (Mpro) inhibitor. GC813 can be used for the research of middle east respiratory syndrome .
loading...
    loading...